Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H22N2O2 |
Molecular Weight | 262.3474 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)NCC(O)COC1=CC=CC2=C1C=C(C)N2
InChI
InChIKey=NXWGWUVGUSFQJC-UHFFFAOYSA-N
InChI=1S/C15H22N2O2/c1-10(2)16-8-12(18)9-19-15-6-4-5-14-13(15)7-11(3)17-14/h4-7,10,12,16-18H,8-9H2,1-3H3
Mepindolol is a selective beta1-adrenoreceptor blocker with intrinsic sympathetic activity. Treatment with mepindolol dose not significantly affect the lipid levels - the total cholesterol in plasma was decreased by mepindolol but HDL-cholesterol increased. During beta-receptor blockade with mepindolol-sulfate angina was compensated, the unfavourable hemodynamic effects seen during placebo did not occur. No signs of congestive heart failure were found during mepindolol-sulfate-therapy. Mepindolol-sulfate showed a pronounced blood-pressure lowering effect.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3759280
10 mg/day for three months
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
||
|
WHO-ATC |
C07AA14
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
||
|
WHO-VATC |
QC07AA14
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C84659
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
DB13530
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
29518
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | RxNorm | ||
|
00Q31ER368
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
71698
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
4001
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
100000081477
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
245-831-1
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
C015340
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
23694-81-7
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
DTXSID40865110
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
m7193
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
1697
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
MEPINDOLOL
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL65717
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY | |||
|
SUB08750MIG
Created by
admin on Sat Dec 16 17:55:25 GMT 2023 , Edited by admin on Sat Dec 16 17:55:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)